HealthcareHUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in ChinaBy Helitra.com·August 31, 2024·1 min read HUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in China Source: SeekingalphaADVERTISEMENT ADVERTISEMENTcancer China drug HUTCHMED pulls regulatory submission Takedapartnered Post navigation Previous storyMediciNova gains after patent win for long COVID therapyNext storyAlnylam falls after full data for heart drug that can rival Pfizer’s
Fitness · HealthcareTired of Basic Pushups? This Dynamic Yoga-Inspired Sweep Hits Chest, Shoulders, and LatsNovember 17, 2026How many years have you been doing good old-fashioned pushups? Probably even longer than you can remember. Pushups are a classic for their…
Fitness · HealthcareThe ‘Godzilla’ of Weight Loss Drugs Could Take ‘Ozempic Face’ to the ExtremeNovember 17, 2026From sunken under-eyes to hollow temples and loose skin, many people using weight-loss drugs report dramatic side effects on their appearance. Now, experts…
Fitness · HealthcareExercise Physiologist Warns This Classic Stretch Before Cold-Weather Workouts Temporarily Cuts Strength by Up to 7.5%November 17, 2026For years, the fitness world has been debating what actually counts as a proper warmup before a workout. Should you sit on the…